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Background and purpose: The aim of this study was to evaluate the prevalence of suicidal
ideation among Polish patients with epilepsy and to assess the potential determinants of
suicidality in this cohort.
Material and methods: The study comprised 301 patients with epilepsy seen in the tertiary
epilepsy clinic. Patients' characteristics included demographic variables, epilepsy-related
variables, as well as occurrence of comorbidities, ongoing use of any other medications,
family history of epilepsy and/or depression. Beck Depression Inventory (BDI) was used to
assess depressive symptoms, and question no. 9 of BDI was speciﬁcally used to reveal
suicidality.
Results: Mean age of subjects was 35.5 years. 113 (37.5%) had frequent seizures and 96
patients (31.9%) had remission. BDI score > 11 points (suggestive for depression) was found
in 127 subjects. Suicidal ideation has been revealed in 30 (10.0%) out of 301 studied patients.
Patients with suicidal ideation were older and more commonly reported frequent seizures.
Almost all of them (93.3%) had clinically signiﬁcant depressive symptoms (BDI score > 11).
Multivariate analysis revealed that severity of depressive symptoms (OR = 1.16 per one-point
increase in BDI score, 95% CI: 1.10–1.22, p < 0.001) and the use of potentially depressogenic
medication (OR = 3.04, 95% CI: 1.04–8.89, p = 0.04) were independent determinants of suicid-
ality among studied patients.
Conclusions: Suicidal ideations were revealed by about 10% of studied epileptic patients
who visited tertiary center for epilepsy. Independent predictors of suicidality among
studied patients included depression itself and the use of potentially depressogenic
medication.
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The risk of suicide is about three times higher among patients
with epilepsy than in general population [1,2]. Psychiatric
comorbidities, such as depression or anxiety, are also more
common among epileptic patients [3,4] and the association
between the presence of psychiatric illness and suicide is well
established [5]. It comes as no surprise, therefore, that the
suicidality among patients with epilepsy is often attributed to
psychiatric disorders.
Recent population-based studies suggest, however, that the
risk of suicide in those patients cannot be fully explained by
the coexistence of psychiatric morbidities [1]. Some other
factors inherent to the epilepsy or its management can play
signiﬁcant role as well, as exempliﬁed by the FDA warning
about the increased risk of suicidal ideation and suicidal
behavior in people treated with antiepileptic drugs (AEDs) [6].
Other potential risk factors for suicide among epileptic
patients included AED polytherapy or high seizure frequency
[7]. Patients newly diagnosed with epilepsy are also at higher
risk of suicide while more advanced age seems to be associated
with the decreasing risk of suicide [1].
Some recent studies suggest also bidirectional association
between depression or suicidal ideation and epilepsy, pointing
to the potential common mechanisms that both increase the
risk of depression/suicidality and decrease the threshold for
seizures [8] which might favor the presence of unrecognized
biological determinant of the suicidality among those patients.
Suicidality in general population is related also to various
sociodemographic and cultural features. Thus, the generali-
zation of ﬁndings obtained in different countries is limited and
justiﬁes the more local approach to that issue. EZOP-Polska
was the only methodologically sound epidemiological study
aimed at the evaluation of prevalence of psychiatric disorders
in Poland [9]. According to this survey, previous suicidal
attempts were reported by 0.7% of both women and men aged
18–64 [10]. Data related speciﬁcally to epileptic patients are
scarce; a single study carried out in 1970s in Poland reported
that 7.3% of deaths among epileptic patients in Warsaw was
due to suicide [11] but no data are available on potential risk
factors related to suicide among Polish patients with epilepsy.
Accordingly, we have designed this study to evaluate the
rate of suicidal ideation among Polish patients with epilepsy,
and, consequently, to assess the potential determinants of
suicidality in this cohort.
2. Materials and methods
2.1. Patients
This study comprised 301 consecutive patients seen in the
tertiary epilepsy clinic in university hospital.
All subjects had epilepsy diagnosed and classiﬁed accord-
ing to the International League Against Epilepsy guidelines
and classiﬁcations [12,13]. The other inclusion criterion was
brain imaging with magnetic resonance imaging (or, rarely,
computed tomography if magnetic resonance imaging was
contraindicated) performed within 5 years preceding theinclusion to this study. The present paper deals with the
suicidality and its determinants, while data related to
depression in the slightly smaller sample of those patients
were published previously [14].
Patients were excluded if they were diagnosed with
concomitant psychogenic non-epileptic seizures or if they
suffered from tonic, atonic, clonic or atypical absence seizures.
We also excluded subjects with some signiﬁcant comorbidities
such as malignancies, neurodegenerative diseases or other
progressive neurological disorders, as well as patients with
current hyper- or hypothyroidism (as suggested by the
abnormal serum thyroxine). Any change in type or dose of
AED(s) within one month preceding the latest visit in an out-
patient clinic also precluded the participation in the study as
did the drug or alcohol abuse. Finally, patients with Mini-
Mental State Examination score < 24 (suggestive for cognitive
impairment) were also excluded.
Our study protocol observed the principles of Helsinki
Declaration and was approved by the university bioethical
committee. The detailed information about the aims and
methods of the study was provided to each participant. Each
subject signed an informed consent to participate.
2.2. Protocol
All procedures required speciﬁcally for this cross-sectional
study were performed during routine visits in out-patient
clinic. Also, we have retrieved data from patients' medical ﬁles.
Medical history was obtained with the use of the question-
naire which comprised information on age, sex, marital status,
vocational activity, etiology and duration of epilepsy, type and
frequency of seizures, ongoing treatment with AED(s), occur-
rence of comorbidities, ongoing use of any other medication(s),
family history of epilepsy and/or depression. Additionally, each
patient underwent neurological examination to reveal any
focal or global signs of brain damage.
Medical history, EEG or video-EEG and neuroimaging were
all used to classify epileptic seizures and epileptic syndromes
according to the International Classiﬁcation of Seizures [13,15]
and International Classiﬁcation of Epilepsies and Epileptic
Syndromes [16]. Seizures were divided into focal (with or
without alterations of alertness/consciousness as well as focal
seizures transformed into bilateral convulsive seizures),
generalized (tonic-clonic, typical absences or myoclonic
seizures) or unclassiﬁed seizures (if information from different
sources was discordant in regard of seizure characteristics).
Epileptic syndromes were classiﬁed into localization-related,
generalized or of unknown onset.
All patients used seizure diaries before entering the study as
an essential part of the management. Frequency of seizures in
the year preceding the inclusion to this study was recorded from
seizure diaries and dichotomized into frequent (at least one per
month) or rare seizures (less than one per month). Complete
remission was deﬁned as being seizure-free for the last year.
The ongoing treatment with antiepileptic drugs (AED) was
recorded according to the information provided by the patient,
and supplemented with the data from medical records.
Patients self-assessed their potential depressive symptoms
with the use of Polish version of revised Beck Depression
Inventory (BDI); the assessment was performed at least 72 h
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 4 3 2 – 4 3 8434after the last seizure (to avoid post-seizure depressive
symptoms) and patients evaluated their depressive symptoms
occurring within one week preceding the assessment. The ﬁrst
version of BDI was validated previously in Polish population
and the cut-off score of 12 points was indicated as the value
suggestive for depression [17]. In the present study, we used
question no. 9 of BDI (suicidal thoughts or wishes) to reveal
potential suicidal thoughts, ranging from 0 ('I don't have any
thoughts of killing myself') to 3 ('I would kill myself if I had the
chance').
Information on comorbidities, including psychiatric ones,
and treatment with drugs other than AEDs, including anti-
depressants, was collected during interview and confronted
with the medical records. We noted the presence of chronic
illnesses, including arterial hypertension, ischaemic heart
disease, history of myocardial infarction, diabetes, hyperch-
olesterolaemia, asthma, as well as corrected hypo- or
hyperthyreosis. All medications taken within 3 months
preceding the study visit were recorded, with the special
focus on the drugs with the potential depression-induction
properties. The list of potentially depressogenic medications
was set according to the literature [18] and originally included
hormones (corticosteroids, estrogens, progesterone), b-block-
ers (mostly propranolol), calcium antagonists (ﬂunarizine),
some antiparkinsonian drugs (levodopa, amantadine), and
interferons.
Family history of epilepsy and/or depression was estab-
lished in interview with the patient or his/her proxies.
2.3. Statistical analysis
Qualitative variables were characterized with numbers and
percentages. Quantitative variables were described with the
use of a mean and standard deviation (SD). Chi-square test
(or Fisher exact test, where appropriate) was used to assess
the signiﬁcance of the differences between the qualitative
data. Student t-test was used to assess differences between
quantitative variables.Table 1 – Comparison of demographic factors and comorbiditie
ideation (univariate analysis). Data shown as n (%) or mean w
Variable Suicidal ideation (n = 30) 
Age 41 (16.2) 
Sex (% of women) 19 (63.3%) 
Marital status (% of living alone) 13 (43.3%) 
Education level
Primary school 5 (16.7%) 
Vocational school 6 (20.0%) 
High school 10 (33.3%) 
College 9 (30.0%) 
Occupational activity (% of active) 7 (23.3%) 
Comorbidities
Arterial hypertension 5 (16.7%) 
Diabetes 0 
Ischaemic heart disease 2 (6.7%) 
History of myocardial infarction 1 (3.3%) 
Hypercholesterolaemia 2 (6.7%) 
Asthma 0 
Hypothyreosis 0 
Hyperthyreosis 0 Initially, univariate analysis of factors that differed be-
tween patients with and without suicidality was made. Then,
analysis of independent factors that inﬂuenced the presence
of suicidality (dependent variable) was performed by logistic
regression modeling. Initial model was built with all the
variables that differed at the level of p < 0.2 in univariate
analysis. Models were created using stepwise method (back-
ward selection with determining criterion likelihood ratio for
variables selection). A p-value of less than 0.05 was considered
statistically signiﬁcant for variables in the ﬁnal model. All the
analyses were performed using Statistica v. 10 (StatSoft Inc.,
Tulsa, OK).
3. Results
We have studied 301 patients, including 180 women (59.8%).
Mean age of subjects was 35.5 years (SD: 14.8). Mean age at
onset of epilepsy was 20.9 years (SD: 15.2), and mean duration
of the disease was 14.7 years (SD: 11.3). Idiopathic generalized
epilepsy was diagnosed in 66 (21.9%) patients, 195 (64.8%) had
focal epilepsy, and further 40 subjects (13.3%) had unclassiﬁed
epilepsy. One hundred and thirteen patients (37.5%) had
frequent seizures (i.e. more often than monthly), and 96
patients (31.9%) had remission (no seizures within the
previous year). BDI score > 11 points (suggestive for depres-
sion) was found in 127 subjects (42.2%). Thirty-ﬁve patients
(11.6%) used potentially depressogenic medications. Mono-
therapy with AED was used in 167 subjects (55.5%).
Suicidal ideation has been revealed in 30 (10.0%) out of 301
studied patients. Twenty-nine of them scored '10 in BDI item
no. 9, and the further one subject scored '20. Thus, we did not
discern patients with different scores in that item in all
analyses.
Table 1 provides details of comparison between patients
with and without suicidal ideation regarding demographic
variables and concomitant disorders. Patients with suicidal
ideation were older and women constituted greater proportions between epileptic patients with or without suicidal
ith standard deviation.
No suicidal ideation (n = 271) p-Value for the difference
34.9 (14.6) 0.035
161 (59.4%) 0.017
164 (60.5%) 0.07
28 (10.3%) 0.22
56 (20.7%) 0.93
137 (50.6%) 0.07
50 (18.5%) 0.13
106 (39.1%) 0.09
35 (12.9%) 0.37
7 (2.6%) 0.30
9 (3.3%) 0.34
3 (1.1%) 0.30
17 (6.3%) –
7 (2.6%)
4 (1.5%)
5 (1.8%)
Table 2 – Comparison of epilepsy characteristics between epileptic patients with or without suicidal ideation (univariate
analysis). Data shown as n (%) or mean with standard deviation.
Variable Suicidal ideation (n = 30) No suicidal ideation (n = 271) p-Value for the difference
Age at onset of epilepsy 25.8 (17.4) 20.3 (14.9) 0.06
Disease duration 15.0 (12.3) 14.6 (11.2) 0.85
Family history of epilepsy 6 (20%) 63 (23.2%) 0.68
Type(s) of seizures
Simple partial 6 (20.0%) 42 (15.6%) 0.53
Complex partial 15 (50.0%) 118 (43.5%) 0.50
Secondary generalized 20 (66.7%) 144 (53.1%) 0.16
Absence 4 (13.3%) 29 (10.7%) 0.42
Myoclonic 3 (10.0%) 25 (9.2%) 0.55
Primary generalized 4 (13.3%) 59 (21.8%) 0.20
Unclassiﬁed 2 (6.7%) 34 (12.5%) 0.27
Treatmenta
Valproate 16 (53.3%) 164 (60.5%) 0.45
Carbamazepine 5 (16.7%) 58 (21.4%) 0.37
Phenobarbital 1 (3.3%) 9 (3.3%) 0.66
Phenytoin 1 (3.3%) 7 (2.6%) 0.57
Clonazepam 3 (10.0%) 7 (2.6%) 0.066
Lamotrigine 6 (20.0%) 33 (12.2%) 0.23
Topiramate 6 (20.0%) 34 (12.5%) 0.25
Levetiracetam 9 (30.0%) 63 (23.2%) 0.41
Gabapentin 1 (3.3%) 14 (5.2%) 0.55
Oxcarbazepine 6 (20.0%) 33 (5.2%) 0.23
Monotherapy 12 (40.0%) 155 (57.2%) 0.07
Frequent seizures (>1/month) 19 (63.3%) 94 (34.7%) 0.002
No seizures in the previous year 5 (16.7%) 91 (33.6%) 0.042
a Other antiepileptic drugs (primidone, vigabatrin, tiagabine, ethosuximide, clobazam) were used by less than 3% of patients in each group.
n e u r o l o g i a i n e u r o c h i r u r g i a p o l s k a 5 0 ( 2 0 1 6 ) 4 3 2 – 4 3 8 435among subjects with suicidality, but otherwise no demograph-
ic factor distinguished those two groups.
The only factor related to epilepsy that differed signiﬁcant-
ly between patients with or without suicidal ideation was
frequency of seizures, with greater proportion of patients
with frequent seizures among patients reporting suicidality
(Table 2). Suicidality was reported by 4 out of 66 patients
with primary generalized epilepsy (6.0%) and by 24 out of
195 patients with focal epilepsy (12.3%) (p = 0.16).
Patients with suicidal ideation signiﬁcantly more often had
history of depression and they used antidepressants more
commonly (Table 3). Also, they more commonly usedTable 3 – Comparison of variables related to depression betwe
(univariate analysis). Data shown as n (%) or mean with stand
Variable Suicidal 
(n = 30)
History of depression 21 (7
Use of antidepressant(s) 20 (6
Use of potentially depression-inducing medication(s)a 8 (2
Family history of depression 6 (2
BDI total score 25.2 (9
BDI, cognitive-affective subscore 16.5 (6
BDI, somatic subscore 8.6 (4
BDI score > 11, suggestive for depression 28 (9
a This category included b-blockers (n = 27), combinations of estrogen and
patients used two of those drugs); BDI–Beck Depression Inventory.depressogenic medication(s) and had much higher scores in
BDI. Vast majority of patients with suicidal ideation had BDI
score > 11, interpreted as suggestive for depression (Table 3).
Multivariate analysis revealed that severity of depressive
symptoms (as expressed in BDI score) and the use of
potentially depressogenic medication(s) were independent
determinants of suicidality among studied patients (Table 4).
When continuous variable (BDI score) was replaced with a
dichotomous one (i.e. presence or absence of depression
reﬂected by BDI score > 11), the model of independent
variables associated with suicidality comprised depression
only (OR = 22.5; 95% CI = 5.2–97.5; p < 0.00001).en epileptic patients with and without suicidal ideation
ard deviation.
ideation No suicidal ideation
(n = 271)
p-Value for the
difference
0.0%) 20 (7.4%) <0.001
6.7%) 16 (5.9%) <0.001
6.7%) 27 (10.0%) 0.007
0.0%) 38 (14.0%) 0.38
.1) 10.4 (8.6) <0.001
.2) 6.5 (5.7) <0.001
.0) 3.9 (3.5) <0.001
3.3%) 99 (36.5%) <0.001
 progestogen (n = 6), corticosteroids (n = 3) and flunarizine (n = 1) (two
Table 4 – Independent predictors of suicidal ideation among studied patients with epilepsy (logistic regression model with
backward elimination).a
Variable Standard error Wald statistics p-Value Odds ratio (95% conﬁdence interval)
Beck Depression Inventory Score 0.025 36.06 <0.00001 1.16 (1.10–1.22)b
Use of depressogenic medications 0.545 4.17 0.04 3.04 (1.04–8.89)
a x2 test = 58.4; p < 0.000001; percentage of appropriate classifications = 91.4%
b Per one-point increase
The following variables were subsequently removed from the model with the backward elimination procedure: sex (p = 0.98), age at onset of
epilepsy (p = 0.98), secondary generalized seizures ( p = 0.99), polytherapy (p = 0.97), frequent seizures (p = 0.67); level of education (p = 0.28);
vocational inactivity (p = 0.38), age ( p = 0.27), marital status (p = 0.40), history of depression (p = 0.13), use of antidepressant(s) (p = 0.19), and use
of clonazepam (p = 0.11).
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Our study revealed that depression, but not factors related to
epilepsy itself, contributes to the occurrence of suicidal
ideation among epileptic patients.
Death by suicide is reported much more commonly among
epileptic patients than in general population. Rates of suicide
in epilepsy vary enormously in relation to country, studied
population and study design, but according to the analysis
cited by Jones et al. [19] about 10% of all deaths in epileptic
patients is due to suicide, which is in marked contrast with 1.1–
1.2% rate in the general population. One-fourth of all subjects
revealing suicidal ideation would ever make a plan to commit
suicide, and about half of those who plan would make an
attempt to do so [20]. Thus, the evaluation of suicidal thoughts
and their relation to demographic and clinical variables seems
to be a prerequisite for further prophylactic measures.
Evaluation of suicidal thoughts faces enormous difﬁculties
and prospective studies notoriously failed to predict suicides
despite fairly good evidence for speciﬁc correlates or risk
factors for suicidality [21]. Several instruments were designed
speciﬁcally to assess suicidal ideation, including Beck's Scale
for Suicide Ideation (BSSI) [22] or Columbia Suicide Severity
Rating Scale (CSSRS) [23], and therefore it may be argued that
they should be used for that purpose. The common practice,
however, is to use BDI as a single measure of suicidal ideation,
as evidenced by longitudinal epidemiological studies [24],
clinical trials [25], or studies aimed at the assessment of
suicidality in epileptic patients [26]. Furthermore, Desseilles
et al. [27] showed that the use of single 'suicidality' item from
BDI might be a valid approach to assess the suicidal ideations
when compared with BSSI. They concluded also that the use of
self-reported questionnaire (BDI) was as useful as clinician-
rated scale (Hamilton Scale for Depression) [27]. Accordingly,
we believe that the use of BDI was in line with the purpose of
our study which focused on the variables related to epilepsy
rather than on more detailed description of suicidality among
our patients.
Other screening methods can be reliably used in the same
way, as recently evidenced by Mula et al. [28]. They studied the
possible use of Neurological Disorders Depression Inventory
for Epilepsy (NDDIE) as a suicidality screening instrument
among 380 epileptic patients in three European countries and
found that the single item 4 ('I'd be better off dead') had
excellent psychometric properties with a good to excellent
sensitivity and speciﬁcity against more elaborated SuicidalityModule of Mini International Neuropsychiatric Interview
(MINI). Again, this ﬁnding conﬁrms the potential utility of
simple screening methods when evaluating epileptic patients
for suicidality. Unfortunately, the Polish version of NDDIE has
not been validated yet.
We have shown that current suicidal ideation can be found
in about 10% of patients with epilepsy. This rate is very similar
to other studies that used the same cross-sectional design.
Hecimovic et al. [26] studied 193 American epileptic patients
seen in tertiary clinic and reported suicidal ideation in 11.9% of
them. The same rate (12.2%) was reported by Jones et al. [19]. It
should be stressed, however, that the estimate provided by our
ﬁndings is valid for the short period that preceded the survey.
It may be reasonably argued that the prevalence and severity
of suicidal ideation vary in longer intervals but it cannot be
captured in a cross-sectional study. The potential confounding
effect of postictal suicidal ideation on the prevalence of
suicidal thoughts in general was also considered but we did
our best to avoid it (BDI was assessed at least 3 days after the
most recent seizure).
Univariate analysis revealed only minimal differences in
demographic and clinical characteristics of patients with and
without suicidal ideation. Firstly, patients who self-reported
suicidal thoughts and wishes were slightly older. This feature
is not limited to patients with epilepsy, however. Indeed,
elderly patients are at the greatest risk for suicide in most
countries [29]. Secondly, the percentage of women was slightly
higher among patients with suicidality which may be viewed
as a ﬁnding contradictory to the results of the studies in a
general population [30]. Nevertheless, it is worthy to note that
women with epilepsy are at slightly greater risk of suicide
than men in population-based studies [1] which may be of
importance regarding speciﬁc biological determinants of
suicidality among women with epilepsy. Finally, patients with
frequent seizures were more prevalent among subjects with
suicidal thoughts. None of above-mentioned variables
retained its signiﬁcance in multivariate analysis, indicating
that the difference between patients with and without suicidal
ideation in regard of those determinants is very likely
explained by the impact of depression in epileptic patients
which was previously associated with female sex [4], older age
[31] and higher frequency of seizures [32].
Depressive symptoms were the only independent determi-
nant of suicidal thoughts and wishes in the studied cohort. BDI
score higher than 11 (indicating clinical depression) was noted
in 93.3% of patients with suicidal ideation and in 36.5% of
other epileptic patients. Both somatic and cognitive-affective
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reported suicidal thoughts. This result was expected, given the
enormous literature that provides very strong link between
psychiatric disorders and suicidality in general population [5],
and among epileptic patients [19,26]. Recently, Christensen
et al. [1] identiﬁed the highest risk of suicide in patients with
epilepsy and concomitant psychiatric disease (OR = 13.7 when
compared to general population) in population-based study.
The detailed discussion of speciﬁc subtypes of depressive
disorders within the cohort of patients reported here was
published elsewhere [14]. It should be highlighted, however,
that only one-quarter of epileptic patients diagnosed by us
with depression was treated with antidepressant(s) at the time
of the survey [33].
Also, the impact of depressogenic medications was more
thoroughly reported in other paper that included vast majority
of patients involved in the present analysis [33]. We interpret
this ﬁnding as yet another conﬁrmation of the overwhelming
inﬂuence of depression on suicidal thoughts. It should be
noted that the ad-hoc deﬁned class of depressogenic medica-
tions did not include AED. None of AED was found to be a risk
factor for suicide ideation in our study.
It may be surprising that we did not identify other
independent determinants of suicidal thoughts among out
patients with epilepsy but actually this is a prevailing
conclusion from other recent studies on that topic [19,26,34].
Once the depression is taken into account in the predictive
model, the signiﬁcance of other variables (frequent seizures,
AED polytherapy, advanced age or female sex) is minor or
none. It is probably due to the fact that most of those factors
increase also the risk of depression itself, and their prognostic
role is 'included' in the effect of depression. Ideally, non-
depressed patients with suicidal thoughts should be analyzed
separately to further evaluate the potential impact of other
factors. We were unable to do so, as only two patients in our
cohort revealed suicidality without high BDI score.
An obvious link between epilepsy and depression and/or
suicidality suggests also some common biological determi-
nants of those manifestations. It has been shown recently that
patients with suicidal ideation or behavior are at much greater
risk of having epilepsy later in their life [8] which could be
explained by shared pathomechanisms of both disorders.
Several plausible abnormalities are thought to be involved,
including dysfunction of serotoninergic neurotransmission,
increased activity of hypothalamic-pituitary-adrenal axis with
resulting higher levels of serum cortisol, as well as an altered
balance between GABA-ergic and glutamatergic neurotrans-
mission (see [35] for review).
Some limitations of the study are acknowledged. The
number of patients involved (n = 301) may be considered as
small but it is actually larger than in most studies of the same
design (i.e. n = 193 [26] or n = 130 [36]). Also, our study was
performed among out-patients visiting epileptic clinic of the
university hospital which limits the generalization of our
ﬁndings. It should be stressed, however, that the majority of
epileptic patients with epilepsy in Poland are managed by
neurologists rather than family physicians and the spectrum
of patients in our clinic is not limited to patients with
refractory epilepsy (as evidenced by the detailed character-
istics provided above). Longitudinal study with the long-termfollow-up would deﬁnitely provide more comprehensive
insight into ever-changing mood disorders and suicidality
among our patients. Yet, we consider our ﬁndings as
exploratory ones and the multi-dimensional evaluation within
the frame of the longitudinal study is planned.
Suicide is a potentially preventable outcome. Neurologists,
very often involved in a long-term follow-up of patients with
epilepsy, should take this opportunity to thoroughly assess the
risk of suicide in their patients and to take precautionary
measures, if required. Results of our study, along with other
lines of evidence, stress the importance of mood disorders in
suicidal ideations. Thus, they should be viewed as a potential
target of any intervention aimed at decreasing the risk of
suicide in patients with epilepsy.
In conclusion, suicidal ideations were revealed by about 10%
of studied epileptic patients who visited tertiary center for
epilepsy. Independent predictors of suicidality among studied
patients included depression itself (expressed either as dichot-
omous variable or as a continuous one, i.e. BDI score > 11)
and the use of potentially depressogenic medication.
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